Intranasal Epinephrine (NS-002)

Access to Epinephrine is a priority for reducing Anaphylaxis. Intranasal Epinephrine aimed at assisting in acute emergency situations. 

nasusphrma taffix

Medical need

Definition: Severe allergic type 1 reaction. Life threatening.
Prevalence: 1.5 % of the US population suffer an event each
(500,000 cases annually)
Cost of treatment 4 B annually
Mortality rates 1.2 % per episode, 30 % recurrence risk lifetime
Epinephrine IM or IV is the first line treatment.

Contact us for more information

To request more information , please submit your contact details below: